Logo image of WKME

WALKME LTD (WKME) Stock Fundamental Analysis

NASDAQ:WKME - Nasdaq - IL0011765851 - Common Stock - Currency: USD

13.95  0 (0%)

After market: 13.93 -0.02 (-0.14%)

Fundamental Rating

4

Taking everything into account, WKME scores 4 out of 10 in our fundamental rating. WKME was compared to 284 industry peers in the Software industry. While WKME has a great health rating, there are worries on its profitability. WKME is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year WKME was profitable.
WKME had a positive operating cash flow in the past year.
In the past 5 years WKME always reported negative net income.
WKME had negative operating cash flow in 4 of the past 5 years.
WKME Yearly Net Income VS EBIT VS OCF VS FCFWKME Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -20M -40M -60M -80M -100M

1.2 Ratios

WKME has a Return On Assets (-9.47%) which is comparable to the rest of the industry.
With a Return On Equity value of -17.23%, WKME perfoms like the industry average, outperforming 45.77% of the companies in the same industry.
Industry RankSector Rank
ROA -9.47%
ROE -17.23%
ROIC N/A
ROA(3y)-18.22%
ROA(5y)-23.44%
ROE(3y)-30.9%
ROE(5y)-46.52%
ROIC(3y)N/A
ROIC(5y)N/A
WKME Yearly ROA, ROE, ROICWKME Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 85.25%, WKME belongs to the top of the industry, outperforming 92.25% of the companies in the same industry.
In the last couple of years the Gross Margin of WKME has grown nicely.
The Profit Margin and Operating Margin are not available for WKME so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 85.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5YN/A
WKME Yearly Profit, Operating, Gross MarginsWKME Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 20 -20 40 -40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

WKME does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for WKME has been increased compared to 1 year ago.
WKME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WKME Yearly Shares OutstandingWKME Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M
WKME Yearly Total Debt VS Total AssetsWKME Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

WKME has an Altman-Z score of 2.93. This is not the best score and indicates that WKME is in the grey zone with still only limited risk for bankruptcy at the moment.
WKME has a Altman-Z score of 2.93. This is comparable to the rest of the industry: WKME outperforms 53.87% of its industry peers.
WKME has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.93
ROIC/WACCN/A
WACC9.55%
WKME Yearly LT Debt VS Equity VS FCFWKME Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M

2.3 Liquidity

A Current Ratio of 2.04 indicates that WKME has no problem at all paying its short term obligations.
WKME has a Current ratio of 2.04. This is in the better half of the industry: WKME outperforms 61.97% of its industry peers.
WKME has a Quick Ratio of 2.04. This indicates that WKME is financially healthy and has no problem in meeting its short term obligations.
With a decent Quick ratio value of 2.04, WKME is doing good in the industry, outperforming 61.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.04
Quick Ratio 2.04
WKME Yearly Current Assets VS Current LiabilitesWKME Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 100M 200M 300M 400M

More info and screens

6

3. Growth

3.1 Past

WKME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 181.25%, which is quite impressive.
Looking at the last year, WKME shows a small growth in Revenue. The Revenue has grown by 4.89% in the last year.
The Revenue has been growing by 21.65% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)181.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.11%
Revenue 1Y (TTM)4.89%
Revenue growth 3Y21.65%
Revenue growth 5YN/A
Sales Q2Q%5.07%

3.2 Future

The Earnings Per Share is expected to grow by 71.00% on average over the next years. This is a very strong growth
WKME is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.86% yearly.
EPS Next Y643.24%
EPS Next 2Y204.11%
EPS Next 3Y147.19%
EPS Next 5Y71%
Revenue Next Year5.65%
Revenue Next 2Y7.5%
Revenue Next 3Y9.56%
Revenue Next 5Y8.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
WKME Yearly Revenue VS EstimatesWKME Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
WKME Yearly EPS VS EstimatesWKME Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 0.4 -0.4 -0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

WKME is valuated quite expensively with a Price/Earnings ratio of 53.65.
WKME's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 26.31. WKME is valued rather expensively when compared to this.
WKME is valuated quite expensively with a Price/Forward Earnings ratio of 50.28.
WKME's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of WKME to the average of the S&P500 Index (22.13), we can say WKME is valued expensively.
Industry RankSector Rank
PE 53.65
Fwd PE 50.28
WKME Price Earnings VS Forward Price EarningsWKME Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, WKME is valued a bit cheaper than the industry average as 77.11% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 28.09
EV/EBITDA N/A
WKME Per share dataWKME EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
WKME's earnings are expected to grow with 147.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.08
PEG (5Y)N/A
EPS Next 2Y204.11%
EPS Next 3Y147.19%

More info and screens

0

5. Dividend

5.1 Amount

WKME does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WALKME LTD

NASDAQ:WKME (9/11/2024, 8:00:44 PM)

After market: 13.93 -0.02 (-0.14%)

13.95

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-01 2024-08-01/amc
Earnings (Next)N/A N/A
Inst Owners9.06%
Inst Owner Change-16.84%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.30B
Analysts51.67
Price Target14.08 (0.93%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)133.64%
Min EPS beat(2)84.28%
Max EPS beat(2)183%
EPS beat(4)4
Avg EPS beat(4)217.58%
Min EPS beat(4)84.28%
Max EPS beat(4)482.59%
EPS beat(8)8
Avg EPS beat(8)132.3%
EPS beat(12)11
Avg EPS beat(12)93.01%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.74%
Min Revenue beat(2)-2.09%
Max Revenue beat(2)-1.38%
Revenue beat(4)0
Avg Revenue beat(4)-1.76%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-1.38%
Revenue beat(8)0
Avg Revenue beat(8)-1.38%
Revenue beat(12)2
Avg Revenue beat(12)-0.97%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-8.05%
EPS NQ rev (3m)-10.24%
EPS NY rev (1m)0.16%
EPS NY rev (3m)7.1%
Revenue NQ rev (1m)-0.13%
Revenue NQ rev (3m)-0.08%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.13%
Valuation
Industry RankSector Rank
PE 53.65
Fwd PE 50.28
P/S 4.76
P/FCF 28.09
P/OCF 27.79
P/B 4.95
P/tB 4.98
EV/EBITDA N/A
EPS(TTM)0.26
EY1.86%
EPS(NY)0.28
Fwd EY1.99%
FCF(TTM)0.5
FCFY3.56%
OCF(TTM)0.5
OCFY3.6%
SpS2.93
BVpS2.82
TBVpS2.8
PEG (NY)0.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.47%
ROE -17.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 85.25%
FCFM 16.93%
ROA(3y)-18.22%
ROA(5y)-23.44%
ROE(3y)-30.9%
ROE(5y)-46.52%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.26%
GM growth 5YN/A
F-Score6
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 8.18%
Cap/Sales 0.18%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.04
Quick Ratio 2.04
Altman-Z 2.93
F-Score6
WACC9.55%
ROIC/WACCN/A
Cap/Depr(3y)42.88%
Cap/Depr(5y)43.23%
Cap/Sales(3y)1.14%
Cap/Sales(5y)1.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)181.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-41.11%
EPS Next Y643.24%
EPS Next 2Y204.11%
EPS Next 3Y147.19%
EPS Next 5Y71%
Revenue 1Y (TTM)4.89%
Revenue growth 3Y21.65%
Revenue growth 5YN/A
Sales Q2Q%5.07%
Revenue Next Year5.65%
Revenue Next 2Y7.5%
Revenue Next 3Y9.56%
Revenue Next 5Y8.86%
EBIT growth 1Y61.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year328.4%
EBIT Next 3Y100.46%
EBIT Next 5Y56.37%
FCF growth 1Y178.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y187.4%
OCF growth 3YN/A
OCF growth 5YN/A